Understand why potassium becomes low, how it affects nerves, skeletal muscle and the heart, and how clinicians build a structured diagnosis for this common electrolyte disorder.
Hypokalemia is one of the most common electrolyte abnormalities in emergency medicine, internal medicine, nephrology and critical care. Although it may be discovered incidentally, it should never be dismissed as a harmless laboratory abnormality because extracellular potassium directly influences membrane excitability and cardiac repolarisation.
This article builds on Electrolytes Explained, Potassium Homeostasis Explained, Acid-Base Disorders Explained, Metabolic Alkalosis Explained and ABG Interpretation Explained.
Most cases of hypokalemia are caused by potassium loss or redistribution into cells. Poor dietary intake alone rarely causes clinically significant hypokalemia when renal function is normal, but it can contribute when ongoing losses or magnesium deficiency coexist.
Serum potassium is not the same as total body potassium. A low serum potassium may reflect true depletion, intracellular shift, or both.

Hypokalemia refers to a serum potassium concentration below the normal laboratory reference range.
Only a small fraction of total body potassium is extracellular, but this extracellular fraction determines the electrical behaviour of excitable tissues. That is why relatively small changes in serum potassium can have major clinical consequences.
Severity is usually classified by serum potassium concentration, but symptoms depend on the speed of onset, underlying heart disease, magnesium status, acid-base status and concurrent medications.
| Severity | Serum Potassium | Typical Clinical Pattern |
|---|---|---|
| Mild | 3.0-3.4 mmol/L | Often asymptomatic, especially if chronic |
| Moderate | 2.5-2.9 mmol/L | Weakness, cramps, ECG assessment usually needed |
| Severe | <2.5 mmol/L | Paralysis, respiratory weakness, arrhythmias or urgent treatment risk |
The ECG and symptoms do not always correlate perfectly with the potassium value. A rapid fall, cardiac disease, digoxin therapy or hypomagnesemia can make even modest hypokalemia clinically important.
Potassium is the major intracellular cation. The Na+/K+-ATPase pump maintains a steep gradient: roughly 98% of body potassium sits inside cells and only about 2% is extracellular.
In skeletal muscle and nerves, low extracellular potassium makes cells less excitable. In cardiac muscle, hypokalemia alters repolarisation and increases susceptibility to ectopy and tachyarrhythmias.
For the physiology behind these shifts, review Potassium Homeostasis Explained.
Nearly all causes of hypokalemia fit into four categories: reduced intake, gastrointestinal loss, renal loss and redistribution into cells.

Reduced intake alone is uncommon as the sole cause because healthy kidneys conserve potassium efficiently. It becomes important in starvation, eating disorders, severe malnutrition, chronic alcoholism, prolonged fasting or restrictive diets, especially when magnesium deficiency or ongoing losses coexist.
Diarrhoea directly removes potassium-rich intestinal fluid and can produce true total body potassium depletion. Vomiting usually causes hypokalemia indirectly through volume depletion, chloride depletion, metabolic alkalosis and secondary hyperaldosteronism, which increase renal potassium excretion.
Other gastrointestinal causes include laxative abuse, high-output ileostomy, enterocutaneous fistula, villous adenoma, chronic intestinal drainage and prolonged nasogastric suction.
Renal potassium wasting should be suspected when urinary potassium remains high despite hypokalemia. Important causes include loop diuretics, thiazide diuretics, mineralocorticoid excess, renal tubular disorders, osmotic diuresis, magnesium deficiency and nephrotoxic drugs such as amphotericin B or cisplatin.
Blood pressure helps narrow the differential. Hypertension suggests mineralocorticoid excess or Liddle syndrome, while normal or low blood pressure may fit diuretics, vomiting, Bartter syndrome or Gitelman syndrome.
In redistribution, serum potassium falls without necessarily reducing total body potassium. Common triggers include insulin, beta2-adrenergic stimulation, metabolic alkalosis, refeeding syndrome and thyrotoxic periodic paralysis.
A medication review is essential in every patient with hypokalemia. Common drug groups include:
Mild chronic hypokalemia is often asymptomatic. Symptoms are more likely when potassium falls rapidly, the deficit is severe, magnesium is low or there is underlying cardiac disease.
| System | Manifestations |
|---|---|
| General | Fatigue, lethargy, malaise |
| Neuromuscular | Weakness, cramps, reduced reflexes, paraesthesia, ascending weakness, paralysis |
| Cardiac | Palpitations, syncope, ectopy, atrial or ventricular arrhythmias |
| Gastrointestinal | Constipation, abdominal distension, paralytic ileus |
| Renal | Polyuria, polydipsia and impaired urinary concentrating ability in prolonged severe cases |
Severe weakness, respiratory muscle involvement, syncope, ventricular arrhythmia, digoxin therapy or significant ECG change should prompt urgent senior clinical review.
Hypokalemia affects cardiac repolarisation. ECG changes are more likely in moderate or severe hypokalemia, but there is no perfectly reliable potassium threshold for a specific ECG pattern.
For a focused comparison of hypokalemia and hyperkalemia ECG morphology, see ECG Changes in Potassium Disorders.

The first task is to determine whether the patient is unstable or at immediate arrhythmia risk. The second task is to identify the mechanism.

Routine evaluation usually includes urea, creatinine, sodium, chloride, bicarbonate, magnesium, calcium, phosphate and glucose. Depending on the context, a venous or arterial blood gas, thyroid function, cortisol, renin and aldosterone may be useful.
Urinary potassium helps distinguish renal from extrarenal potassium loss. Low urinary potassium suggests gastrointestinal loss, reduced intake or redistribution. High urinary potassium suggests renal potassium wasting from diuretics, mineralocorticoid excess, tubular disorders or magnesium deficiency.
Acid-base status provides important diagnostic clues. Metabolic alkalosis commonly accompanies vomiting, diuretic use and mineralocorticoid excess. Metabolic acidosis suggests diarrhoea or renal tubular acidosis. Review Metabolic Alkalosis Explained, Metabolic Acidosis Explained and ABG Interpretation Explained for the acid-base framework.
Treatment depends on severity, symptoms, ECG findings and the underlying cause. Management should correct both the potassium abnormality and the mechanism producing it.
Detailed potassium replacement regimens are intentionally deferred to the dedicated Potassium Replacement Explained article. This page focuses on recognition, mechanism and diagnostic reasoning.
Untreated hypokalemia can cause ventricular tachycardia, ventricular fibrillation, sudden cardiac death, progressive weakness, paralysis, respiratory failure, rhabdomyolysis, paralytic ileus, polyuria and nephrogenic diabetes insipidus in prolonged severe cases.
Prognosis is usually good when hypokalemia is recognised early, potassium is corrected safely and the underlying cause is treated. Severe untreated hypokalemia may be fatal because of malignant ventricular arrhythmias.
Hypokalemia is common, but its significance depends on physiology, clinical context and the speed of potassium change. A structured approach helps clinicians distinguish true potassium depletion from intracellular redistribution, identify gastrointestinal or renal losses, recognise ECG risk and correct the underlying disorder rather than treating the number alone.
This article is intended for educational purposes. It should not replace clinical judgement, institutional protocols or specialist advice. Laboratory results should always be interpreted within the patient's clinical context.